![Charles Kunsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Kunsch
Direktor/Vorstandsmitglied bei CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Aktive Positionen von Charles Kunsch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Direktor/Vorstandsmitglied | 01.04.2024 | - |
Kojin Therapeutics, Inc.
![]() Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Direktor/Vorstandsmitglied | 01.09.2021 | - |
Aquinnah Pharmaceuticals, Inc.
![]() Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.04.2017 | - |
Massachusetts Biomedical Initiatives | Direktor/Vorstandsmitglied | 01.10.2020 | - |
Accent Therapeutics, Inc.
![]() Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Direktor/Vorstandsmitglied | 01.07.2021 | - |
Dg Medicines
![]() Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Direktor/Vorstandsmitglied | 01.12.2021 | - |
Endlyz Therapeutics, Inc.
![]() Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Direktor/Vorstandsmitglied | 01.08.2021 | - |
Penn State Research Foundation
![]() Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Charles Kunsch
Ehemalige bekannte Positionen von Charles Kunsch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AbbVie Ventures LLC
![]() AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01.09.2013 | 01.10.2023 |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Charles Kunsch
Drexel University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Polen | 2 |
Operativ
Director/Board Member | 8 |
Private Equity Investor | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 8 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Health Technology |
Private Unternehmen | 9 |
---|---|
AbbVie Ventures LLC
![]() AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
Kojin Therapeutics, Inc.
![]() Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AtheroGenics, Inc.
![]() AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Aquinnah Pharmaceuticals, Inc.
![]() Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Massachusetts Biomedical Initiatives | |
Accent Therapeutics, Inc.
![]() Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Health Technology |
Dg Medicines
![]() Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Health Technology |
Endlyz Therapeutics, Inc.
![]() Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Health Technology |
Penn State Research Foundation
![]() Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Commercial Services |
- Börse
- Insiders
- Charles Kunsch
- Erfahrung